MedTrace Logo

Clinical Evaluation of CelluTite Treatment

NCT03769649 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2022-06-08

Study results available
· View outcomes & findings →

Summary

This prospective study is intended to evaluate the CelluTite RFAL handpiece combined with Morpheus8 handpiece for the treatment of cellulite.

Conditions

  • Cellulite of Thighs

Interventions

DEVICE

CelluTite

CelluTite: Radiofrequency-assisted lipolysis (RFAL) Morpheus8: Fractional RF

Sponsors & Collaborators

  • InMode MD Ltd.

    lead INDUSTRY

Principal Investigators

  • Bruce Katz, MD · 60 E 56th St #2, New York, NY 10022, USA

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-12
Primary Completion
2020-01-17
Completion
2020-01-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03769649 on ClinicalTrials.gov